Company Vitrolife AB

Equities

VITR

SE0011205202

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Vitrolife AB

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Diagnostic & Testing Substances

Market Closed - Nasdaq Stockholm Other stock markets 11:29:32 2024-04-26 am EDT			5-day change	1st Jan Change
163.3 ^SEK	+3.62%		-0.24%	-16.13%

Apr. 18	Nordic Stocks Closed Down Thursday; Arjo Series B Fell Furthest	DJ
Apr. 18	Transcript : Vitrolife AB, Q1 2024 Earnings Call, Apr 18, 2024

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Companyâs product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

Number of employees: 1,132

SEK in Million	2022	Weight	2023	Weight	Delta
Consumables 43.5 %	1,339	41.4 %	1,528	43.5 %	+14.12%
Genetic 38.3 %	1,343	41.5 %	1,344	38.3 %	+0.07%
Technology 18.2 %	553	17.1 %	640	18.2 %	+15.73%

SEK in Million	2022	Weight	2023	Weight	Delta
EMEA 30.1 %	927	28.7 %	1,057	30.1 %	+14.02%
United States 22.4 %	797	24.6 %	786	22.4 %	-1.38%
APAC 14.9 %	-	-	524	14.9 %	-
North and South America 10.6 %	347	10.7 %	373	10.6 %	+7.49%
China 8.2 %	250	7.7 %	287	8.2 %	+14.80%
Japan 7.3 %	240	7.4 %	255	7.3 %	+6.25%
Spain 5.1 %	190	5.9 %	180	5.1 %	-5.26%
Denmark 0.8 %	24	0.7 %	28	0.8 %	+16.67%
Sweden 0.6 %	22	0.7 %	21	0.6 %	-4.55%

Managers	Title	Age	Since
Bronwyn Brophy CEO	Chief Executive Officer	-	23-07-31
Patrik Tolf DFI	Director of Finance/CFO	54	21-12-31
Sigurdur Sigurðsson CHM	Chairman	68	15-05-06
Claus Bisgaard CTO	Chief Tech/Sci/R&D Officer	47	16-12-31
Carlos Antonio Simon Valles CTO	Chief Tech/Sci/R&D Officer	-	21-12-31
Guillermo Ferrando PRN	Corporate Officer/Principal	33	19-12-31
Karin Koritz Russberg HRO	Human Resources Officer	55	19-12-31
Rickard Ericsson SAM	Sales & Marketing	53	14-12-31
Kristoffer Forsmark PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Henrik Gustaf Blomquist BRD	Director/Board Member	53	19-05-01
Sigurdur Sigurðsson CHM	Chairman	68	15-05-06
Lars Erik Holmqvist BRD	Director/Board Member	64	18-04-26
Pia Marions BRD	Director/Board Member	61	13-04-18
Karen Lykke Sörensen BRD	Director/Board Member	62	20-06-14

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	135,447,190	75,026,930 ( 55.39 %)	52,568 ( 0.0388 %)	55.39 %

Name	Equities	%	Valuation
William Demant Fonden 28.67 %	38,829,825	28.67 %	730 M kr
BURE EQUITY AB 15.88 %	21,510,257	15.88 %	404 M kr
AMF Fonder AB 5.092 %	6,896,810	5.092 %	130 M kr
Swedbank Robur Fonder AB 4.044 %	5,478,118	4.044 %	103 M kr
Alfred Berg Kapitalförvaltning AB 2.364 %	3,201,700	2.364 %	60 M kr
Cliens Kapitalförvaltning AB 1.842 %	2,495,271	1.842 %	47 M kr
Tredje AP-fonden 1.286 %	1,742,207	1.286 %	33 M kr
Norges Bank Investment Management 1.127 %	1,525,963	1.127 %	29 M kr
Eccenovo AB 0.9967 %	1,350,000	0.9967 %	25 M kr
C Worldwide Asset Management Fondsmæglerselskab A/S (Sweden) 0.9853 %	1,334,507	0.9853 %	25 M kr

Vitrolife AB

Gustaf Werners Gata 2

421 32, Gothenburg

+46 31 721 80 00

http://www.vitrolife.com

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

163.3 SEK

Average target price

231.7 SEK

Spread / Average Target

+41.87%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
VITROLIFE AB	-16.13%	2.02B
BIOMÉRIEUX	+0.89%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-10.29%	7.61B
DIASORIN S.P.A.	+1.78%	5.41B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.16%	4.51B
LANTHEUS HOLDINGS, INC.	+5.74%	4.49B
10X GENOMICS, INC.	-50.70%	3.3B
ANDON HEALTH CO., LTD.	+12.21%	2.73B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.50%	1.73B
MYRIAD GENETICS, INC.	-5.02%	1.64B

Diagnostic & Testing Substances